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Abstract
The endothelial glycocalyx (eGC) plays a pivotal role in the physiology of the vasculature. By binding plasma proteins, the
eGC forms the endothelial surface layer (ESL) which acts as an interface between bloodstream and endothelial cell surface.
The functions of the eGC include mechanosensing of blood flow induced shear stress and thus flow dependent
vasodilation. There are indications that levels of plasma sodium concentrations in the upper range of normal and beyond
impair flow dependent regulation of blood pressure and may therefore increase the risk for hypertension. Substances,
therefore, that prevent sodium induced endothelial dysfunction may be attractive for the treatment of cardiovascular
disease. By means of combined atomic force - epifluorescence microscopy we studied the impact of the hawthorn
(Crataegus spp.) extract WS 1442, a herbal therapeutic with unknown mechanism of action, on the mechanics of the ESL of
ex vivo murine aortae. Furthermore, we measured the impact of WS 1442 on the sodium permeability of endothelial EA.hy
926 cell monolayer. The data show that (i) the ESL contributes by about 11% to the total endothelial barrier resistance for
sodium and (ii) WS 1442 strengthens the ESL resistance for sodium up to about 45%. This mechanism may explain some of
the vasoprotective actions of this herbal therapeutic.
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Introduction
The daily sodium intake in industrial countries greatly exceeds
physiological needs. There is a strong correlation between the
daily sodium intake and the prevalence of arterial hypertension,
one of the main risk factors of cardiovascular disease and mortality
worldwide [1]. One important mechanism of blood pressure
regulation is blood flow dependent vasodilation, which in turn is
sensitive to changes in the plasma concentration of sodium [2]. In
previous studies we showed that high plasma sodium may promote
aldosterone-mediated hypertension by diminishing the release of
the vasodilator nitric oxide (NO) [3]. Blood flow dependent
vasodilation is also controlled by heparan sulfate residues
functioning as mechanosensors in the endothelial glycocalyx
(eGC) [4–6]. The eGC is an anionic biopolymer that covers the
luminal side of blood vessels. It consists of proteoglycans and
glycoproteins with attached polysaccharide side chains, also
referred to as glycosaminoglycans. By binding plasma constituents
eGC forms the endothelial surface layer (ESL) – an interface
between blood and endothelial cell surface [7]. The ESL plays a
pivotal role in the endothelial barrier function including the
regulation of vascular permeability [8] and extravasation of
colloids and fluids [9,10]. Furthermore, the ESL forms a
regulatory microdomain for many processes on the membrane
surface such as lipolysis [11], inactivation of procoagulant species
[12] and recruitment of leukocytes to the subendothelium [13,14].
Recently it was shown that high plasma sodium damages the
endothelial glycocalyx [15].
Fluid shear stress induces a conformational change of heparan
sulfate proteoglycans of the eGC from a random coiled state to an
unfolded state. The unfolded structure reveals sodium binding sites
and promotes transmembrane Na
+-influx by counter-ion migra-
tion along the polysaccharide. This process causes a vasodilatory
response [2,16]. Thus, substances that protect the ESL and
increase endothelial NO-release could provide interesting ther-
apeutical approaches to fight sodium induced hypertension and
possibly other cardiovascular diseases.
Hawthorn extracts have been used in Europe for many decades
to treat cardiovascular diseases. It has been shown that hawthorn
extract WS 1442 induces an endothelium dependent, NO and
EDRF mediated vasorelaxation [17,18] and is cardioprotective in
ischemic reperfusion injuries [19,20]. Hawthorn extracts exhibit
antioxidative properties and inhibit neutrophil elastase [21]. The
efficacy and safety of WS 1442 was demonstrated in numerous
clinical studies [22–29]. A recently published review [30]
summarizes some pharmacological and clinical data of hawthorn
extracts.
To test, whether WS 1442 modulates the functional properties
of the ESL, we established a method using combined atomic force
microscopy (AFM) - epifluorescence microscopy. This approach
makes it possible to observe in real time eGC height and stiffness
[31,32], and simultaneously, examine eGC-constituents by means
of immunofluorescence . Though there is considerable knowledge
about the permeability of the ESL to macromolecules [33–35],
there are no data concerning its selective ion permeability. To test
whether sodium ions can freely pass the ESL, we compared the
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control conditions and under conditions where the eGC was
enzymatically digested. Furthermore, we measured the PNa+ of WS
1442 treated cells to analyze the link between the mechanical state
of the ESL and PNa+.
Materials and Methods
Cell culture
Human endothelial EA.hy 926 cells (kindly provided by Cora-
Jean Edgell, University of North Carolina, USA) and bovine aortic
endothelial GM 7373 cells (DSMZ, Braunschweig, Germany)
were cultured at 37uC and 5% CO2. For GM 7373, minimal
essential medium (Invitrogen Corp., La Jolla, CA, USA)
supplemented with 20% fetal calf serum (FCS; PAA Clone,
Coelbe, Germany), 1% MEM vitamins (Invitrogen), 1% MEM
nonessential amino acids (Invitrogen) and 1% Pen-Strep (Invitro-
gen) was used. EA.hy 926 cells were cultured in Dulbecco’s
modified Eagle’s medium (Invitrogen) supplemented with 1% Pen-
Strep solution and 10% FCS.
Preparation of ex vivo aortae
All animal procedures were performed in accordance with the
guidelines of the Charite ´, Universita ¨tsmedizin Berlin, and were
specifically approved by the Landesamt fu ¨r Gesundheit und
Soziales (LaGeSo, Berlin, Germany) for the use of laboratory
animals (G0355/09) and followed the ‘‘Principles of Laboratory
Animal Care’’ (NIH publication No. 86-23, revised 1985), as well
as the current version of German Law on the Protection of
Animals.
Mouse aortae were isolated and freed from surrounding tissue.
A small patch (about 1 mm
2) of the whole aorta was removed and
attached on Cell-TakH coated glass, with the endothelial surface
facing upwards. The artery preparation was bathed in PBS (PAA
Clone). After preparation, the segments were stored in minimal
essential medium supplemented with 20% FCS, 1% MEM
vitamins, 1% MEM nonessential amino acids and 1% Pen-Strep.
Immunostaining of heparan sulfates
As primary antibody, mouse anti-heparane sulfate (10E4
epitope) antibody (AMS Biotechnology, Abingdon Oxon, UK)
and as secondary antibody, Qdot 655 goat anti-mouse antibody
conjugate (Invitrogen), were used. GM 7373 cells were seeded on
Ø35 mm cell culture glass bottom dishes (Willco, Amsterdam,
Netherlands) for 72 h until a confluent cell monolayer was formed.
The primary antibody (1:500) was added to the living cells directly
into the cell culture medium. After 30 min incubation at 37uC the
cells were washed 365 min with PBS (37uC). Next, the secondary
Qdot antibody conjugate was added (1:800). The cells were again
incubated for 30 min and washed 365 min in PBS at 37uC. PBS
was removed and HEPES buffered solution (standard composition
in mM: 135 NaCl; 5 KCl; 1 MgCl2; 1 CaCl2; 10 HEPES (N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid); pH 7.4), sup-
plemented with 1% FCS, was added.
Simultaneous atomic force and immunofluorescence
microscopy
Using a BioScope Catalyst AFM (Bruker, Karlsruhe, Germany)
combined with a Leica DMI 6000 B inverted fluorescence microscope
(Leica Microsystems, Wetzlar, Germany), the nanomechanical
properties of the ESL were monitored in dependence of the amount
of heparan sulfates. Simultaneous indentation measurements and
immunofluorescence microscopy (figure 1) were performed before and
after the eGC of endothelial GM 7373 cells was enzymatically
digested by heparinase I (1 SigmaU/ml=0.002 U/ml, 45 min at
27uC). For AFM-measurements a soft cantilever (spring constant=18
pN/nm; Novascan, Ames, IA, USA) with a spherical tip (sphere
diameter=1 mm) and a maximal loading force in the range of 400 pN
was used. Qdot fluorescence was excited using a wavelength of
400 nm, whereas the emission was detected at 655 nm.
Indentation measurements provide information about K, the
sample stiffness. K is the mechanical resistance of a sample against




whereby F is the applied force and x is the displacement caused by
the applied force to the sample. In this work, K is measured as the
slope of the obtained force-distance curve (figure 2). Since cells
consist of a vast number of different substructures and organelles,
K depends strongly on indentation depth and location.
Figure 1. Combined atomic force and fluorescence microscopy. Using this setup, we performed force-distance measurements and
immunofluorescence microscopy simultaneously in living endothelial cells to study the mechanical properties of the ESL (force-distance curve; upper
right) in dependence of the amount of heparan sulfates (Qdot staining; lower right). The scale bar in the fluorescence image is 10 mm.
doi:10.1371/journal.pone.0029972.g001
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Force-distance measurements on murine ex vivo aortae were
performed to examine the impact of the hawthorn extract WS
1442 on ESL stiffness and ESL height. For this series of
experiments a Multimode AFM (Veeco, Mannheim, Germany)
was used with the same parameters as for the Catalyst AFM setup.
ESL stiffness and ESL height of murine ex vivo aortae were
obtained before and after application of 10 mg/ml WS 1442 for
30 min.
Sodium permeability assay
EA.hy 926 cells were grown on filter membranes (high density
filter with 0.4 mm pore diameter; Greiner Bio One, Frickenhau-
sen, Germany) in 12-well plates (Greiner Bio One, Frickenhausen,
Germany) for 4 days. The control group was grown in standard
cell culture medium, the WS 1442 group was grown in standard
cell culture medium containing 10 mg/ml WS 1442. Prior to the
experiment, medium with a sodium concentration of 155 mM
(apical side) and 130 mM (basolateral side) was applied.
Osmolarity was maintained constant by the addition of appropri-
ate amounts of mannitol. After 2 hours of incubation at 37uC and
5% CO2, the basolateral sodium concentration was determined.
The sodium concentration of the medium was obtained by means
of a Radiometer EML 105 electrolyte analyser (Radiometer
Copenhagen, Copenhagen, Denmark). The sodium permeability




where DCBL is the change of the basolateral Na
+ concentration
and CA is the apical sodium concentration (considered to remain
constant through the experiment). VBL is the basolateral fluid
volume, S is the surface area of the filter membrane and Dt the
time of incubation. To test whether PNa+ depends on the ESL, we
applied heparinase I (1 SigmaU/ml, 37uC; Sigma-Aldrich Chemie
GmbH, Munich, Germany) directly into the medium for 30 min
prior to the experiment. Again, the medium was replaced with
high sodium medium and PNa+ was obtained as described above.
Results
Quantification of the nanomechanical properties of the
ESL by AFM
The extracellular matrix of human cervical epithelial cells can
be characterised by using AFM methods [36]. Our main goal was
to establish a method to analyse the mechanical properties of the
ESL by means of simultaneous AFM and immunofluorescence
measurements. The data reveal a soft layer on the surface of the
GM 7373 cells with a stiffness of about 0.32 pN/nm which is
about 4 times softer than the cortical stiffness of endothelial cells.
Heparinase treatment leads to a reduction in this stiffness by 47%
(Figure 3A) as well as to a reduction in the heparan sulfate
abundance on the cell surface by 34% (Figure 3B). This approach
provides evidence that the ESL can be detected by AFM because
the measured ESL stiffness and the amount of stained heparan
sulfate decreased in an interdependent way after heparinase
treatment. Furthermore, the ESL stiffness correlates strongly with
the amount of stained heparan sulfates (Spearman’s correlation
coefficient R
2=0.75, p,0.01; Figure 3C). Similar experiments
using AFM for measuring ESL stiffness have recently been
published [15,37].
WS 1442 modulates the functional properties of the ESL
Previous work has shown that WS 1442 exhibits vasoprotective
properties. Some of these effects, such as an increase of NO-
synthesis [17,18] and cardioprotective effects in ischemic
reperfusion injuries [20] could be related to the proper
functioning of the ESL. To prove, whether WS 1442 has an
impact on the ESL, we measured the mechanical properties of
the endothelial surface layer by means of AFM. The advantage of
the AFM is the possibility to measure living cells under
physiological conditions. For the AFM experiments murine ex
vivo arteries were used, in order to emulate physiological
conditions as closely as possible. That it is feasible to use ex
vivo arteries for AFM measurements has been shown previously
[38]. Time-response experiments show that WS 1442 develops its
maximal effect 30 min after administration (data not shown). The
nanomechanical properties of the ESL were measured before and
after administration of WS 1442 (10 mg/ml, 30 min, 37uC). For
each group we measured six different sites on six different aortic
preparations respectively, and each measurement represents an
average of 50 force-distance curves. Measurements of the control
group revealed a soft surface layer with an average stiffness of
0.6060.007 pN/nm (mean 6 SEM) and an average thickness of
65.5461.06 nm. After WS 1442 treatment, the ESL becomes
softer and thicker - the stiffness decreases by 30% to 0.4260.006
pN/nm (Figure 4A) and the thickness rises by 22% to
79.5461.32 nm (Figure 4B). These changes are highly significant
(p,0.01, Mann-Whitney U-Test). Due to the lack of transparency
of the aortic preparations, the simultaneous AFM and fluores-
cence microscopy could not be applied. To test, whether the
changes of the mechanical properties of the ESL were due to
conformational (e.g. collapse) or structural (e.g. loss of ESL
constituents) alterations, we compared the amount of heparan
sulfates between WS 1442-treated cells and untreated cells.
Interestingly, the amount of heparan sulfates was not altered after
30 min of WS 1442 - treatment (Figure 4C).
Figure 2. Schematic illustrating the different layers detectable
by the indentation measurements. (A). Representative example of
a force-distance curve obtained in a human endothelial cell (EA.hy 926
cell line) giving information about stiffness at defined indentation
depths (B).
doi:10.1371/journal.pone.0029972.g002
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In a permeability assay we studied the PNa+ of the endothelial
cells before and after heparinase digestion of the ESL. The
measured values (median and interquartile range (IQR)) are as
follows: PNa+=11.7*10
26 (IQR: 2.7*10
26, n=24) cm/s for the
control group and PNa+=9.8*10
26 (IQR: 4.3*10
26, n=24) cm/s
for the WS 1442-treated group. After heparinase treatment, the
PNa+ of the control group rises by 12% to 13.1*10
26 (IQR:
3.6*10
26, n=24) cm/s while the PNa+ of the WS 1442-treated
group rises by 24% to 12.2*10
26 (IQR: 3.1*10
26, n=12) cm/s
(Figure 5). Statistical comparison of the groups reveals the
following: the ESL contributes to the PNa+ of the endothelial cells
because after enzymatically digestion of the eGC, PNa+ is found to
be significantly increased (p,0.017, Mann Whitney U-Test,
Bonferroni corrected). WS 1442-treated endothelial cells show
significantly lower PNa+ (p,0.017) in contrast to the cells of the
control group. This WS 1442 induced reduction of the PNa+ is
most likely caused by modifications of the ESL since both the
control group and the WS 1442-treated group show no difference
in PNa+ after heparinase treatment.
Discussion
Influence of WS 1442 on the ESL
The results show that WS 1442 induces a change of the
mechanical properties of the ESL within a few minutes. The ESL
becomes 30% softer and 22% thicker. As WS 1442 does not
influence the amount of heparan sulfate molecules at the surface of
endothelial cells, it is assumed that the nature of the eGC-
modulation is a result of conformational alterations. From our
Figure 3. Effect of heparinase treatment on the ESL (n=6, 10
measurements per n). After heparinase application for 45 min the
ESL-stiffness (A) and the amount of heparan sulfate molecules (B) of the
ESL decrease significantly. The amount of heparan sulfates strongly




Figure 4. Impact of WS 1442 on the ESL-stiffness, the ESL-
height (n=36, 50 force-distance curves per n respectively) and
the amount of heparan sulfates (n=12). After administration of
10 mg/ml WS 1442 for 30 min the ESL becomes softer (A) and thicker
(B), whereas the amount of heparan sulfates remains constant (C).
Shown were median, IQR (box) and SD (whiskers).
doi:10.1371/journal.pone.0029972.g004
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glycans in the ESL is a regulated process. Loss of ESL constituents
like heparan sulfate leads to structural changes of the ESL and thus
to decreased height and stiffness. In contrast, as observed after WS
1442 treatment, the amount of ESL constituents can remain also
constant while height and stiffness change. A similar behaviour
was observed by Sui et al. [39] for artificial surface-tethered
polymer brushes. After solvent exchange the polymer brushes
switch from a swollen to collapsed state within few seconds,
leading to a decrease in thickness and an increase in stiffness of the
polymer layer. So it is possible that the changes in the ESL
mechanics measured in our study result from an alteration of the
solvation state of the ESL. Changes in the mechanical properties
of the ESL may lead to a change in haemodynamics [40]. A
change in ESL could regulate processes on the cell surface such as
receptor-ligand interactions. It is possible that the nanomechanical
properties of the ESL influence the biochemistry of this structure,
e.g. by regulating the number of binding sites for different blood-
borne substances. The ESL also plays an important role in
inflammatory processes [41,42] which may explain the anti-
inflammatory properties of WS 1442. Since the eGC is crucial for
shear stress mechanotransduction [4–6], it is possible that a softer
and thicker glycocalyx results in a better detection of shear stress
by the endothelium and thus higher NO-synthesis and release.
With the use of ex vivo arteries physiological conditions are
mimicked as closely as possible [38]. Nevertheless the in vivo
situation may be different because of the absence of factors such as
fluid shear stress or hormones ex vivo. Application of transmission
electron microscopy shows that the ESL-height could be up to a
few mm [43], in contrast to 40–300 nm measured in the present
study. A possible explanation for this apparent discrepancy may be
that the ESL itself is a multilayer structure containing layers of
different composition and functional properties [44]. Our AFM
approach, therefore, can detect stiffness only in those more dense
ESL-regions which are close to the plasma membrane.
Sodium permeability
As the results revealed that WS 1442 modulates the mechanical
properties of the ESL, there was a need to test whether these
modulations cause an alteration of the ESL-dependent endothelial
barrier function. Comparison of the PNa+ of control cells to those
after heparinase digestion of the eGC does reveal that the ESL
significantly contributes to the PNa+ of the endothelium. In
addition, the permeability depends on the physiological state of
the ESL. This conclusion is derived from the observation that WS
1442 treated cells show a significantly lower PNa+ in comparison to
untreated cells. This difference completely disappeared after
heparinase treatment, so it is assumed that the changes of PNa+
are a result of modulation of the ESL. This conclusion is
strengthened by the assumption that the total resistance RNa+ - the
reciprocal value of permeability (RNa+=1/PNa+)-of the endothe-
lial cell monolayer is determined by the combined resistance of the













Because the sodium permeability of the filter membrane is
extremely high, the term 1/PNa+(filter) is very small and thus
negligible for further calculations. If it is assumed that after the
ESL digestion PNa+ depends only on the permeability of the






Table 1 summarizes the values for the measured PNa+(total),
PNa+(cell layer) and the calculated PNa+(ESL). In vivo, a lower
endothelial PNa+ would result in a lower rate of sodium transfer
from the blood across the endothelium to the interstitium. This
mechanism may help retain sodium in the circulation and thus
accelerate renal sodium excretion.
A bath sodium concentration in the high physiological range
impairs endothelial cell function e.g. NO-synthesis [3]. In contrast
to the effect of an increase in plasma sodium, WS 1442 increases
Figure 5. The sodium permeability PNa+ of a cell monolayer
(EA.hy 926 cells. Heparinase induced digestion of the ESL leads
to an increase of PNa+ (n=24). In contrast, cells treated with 10 mg/
ml WS 1442 show a lower PNa+ (n=24). The difference in PNa+ between
WS 1442-treated and untreated cells vanishes completely after
enzymatic digestion of the ESL.
doi:10.1371/journal.pone.0029972.g005
Table 1. Sodium permeability PNa+ of human vascular endothelium (EA.hy 926 cell monolayer).
Group PNa+(total) (10
26 cm/s) measured (IQR; n) PNa+(cell layer) (10
26 cm/s) measured (IQR; n) PNa+(ESL) (10
26 cm/s) calculated (IQR)
Control 11.7 (2.7; 24) 13.1 (3.6; 24) 110.4 (100.4)
WS 1442 9.8 (4.3; 24) 12.2 (3.1; 12) 50.4 (48.3)
Statistics (Mann Whitney U-Test with Bonferonni correction): PNa+(total) is significantly smaller than PNa+(cell layer) of control group (p,0.05) and WS 1442 group
(p,0.01). PNa+(total) of the WS 1442 group is significantly smaller in comparison to PNa+(total) of the control group(p,0.05). There is no significant difference in PNa+(cell
layer) between control group and WS 1442 group.
doi:10.1371/journal.pone.0029972.t001
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the ESL decreases as shown in the present study. This may explain
mechanistically how hawthorn extracts exert their protective
effects on the cardiovascular system.
Vascular effects of WS 1442 have been related to its high
content of oligomeric procyanidins (OPCs) (16). Red wine and
purple grape juice polyphenols also exert beneficial effects on the
cardiovascular system by enhancing NO-release [45] and
inhibiting smooth muscle cell migration [46]. It is possible
therefore that WS 1442 induced ESL modulation is mediated by
OPCs. The identification of ESL modulating components will be
necessary for further investigation of this issue.
In conclusion, the results show that hawthorn extract WS 1442
leads to a softer and higher ESL companied by a reduction of the
PNa+(ESL) (figure 6). This may explain some of the vasoprotective
properties of the herbal extract.
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